31st Annual International Prostate Cancer Update

Cliff Lodge, Snowbird, Utah
July 14-18, 2021

innovations in urologic practice logo

GRU Presents the 31st International Prostate Cancer Update

The International Prostate Cancer Update (IPCU), is a multi-day, CME-accredited conference focused on prostate cancer treatment updates. IPCU 31 will feature lectures, interactive panel discussions, debates, and case-based presentations. This conference is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer.

The goal of this educational program is to equip healthcare professionals involved in the diagnosis and treatment of prostate cancer with the up-to-date clinical knowledge and tools they need to best treat their patients. The program will discuss the treatment of prostate cancer from diagnosis to treating advanced and metastatic disease. The conference aims to give physicians exposure to a comprehensive review of how to treat prostate cancer and to give them a chance to discuss key issues with peers and experts.

Program Director

E. David Crawford, MD

E. David Crawford, MD

Professor of Urology
University of California, San Diego
San Diego, California

Keynotes from Prostate Cancer Experts

Attend Sessions

Connect with Peers and Experts

Agenda

The International Prostate Cancer Update offers a comprehensive update on the treatment of prostate cancer patients in its program. Join us from July 14-18, 2021, in Park City, Utah.

Wednesday, July 14, 2021

12:00pm–6:00pm

Open Advisory Board Slots

12:00pm–9:00pm

Faculty Slide Review

3:00pm–6:00pm

Registration Desk Opens/Exhibitor Sign-in/Set Up

4:00pm–6:00pm

SESSION 1: Men’s Prostate Health
Moderators: Mark A. Moyad, MD, MPH, and E. David Crawford, MD

4:00pm–4:15pm

Prostate Cancer and the Role of Nutrition
Mark A. Moyad, MD, MPH

4:15pm–4:30pm

Applied Human Research and Prevention of Chronic Disease
Wesley Smith, PhD

4:30pm–4:45pm

The Third Dimension in Prostate Cancer Diagnosis
Francisco G. La Rosa, MD

4:45pm–5:00pm

Highlights of Prostate Cancer Advances As Covered in ASCO-SEP: A Training and Board Certification Program for Medical Oncologists Worldwide
Marc B. Garnick, MD

5:00m–5:15pm

Early Diagnosis of Prostate Cancer: A Path Forward 
E. David Crawford, MD

5:15pm–5:25pm

Patient Advocacy: Advocate Perspective
Wendy L. Poage, MHA

5:25pm–6:00pm

LUGPA Government Policy Panel
Moderator: R. Jonathan Henderson, MD (LUGPA President)
Panelists: Deepak A. Kapoor, MD, FACS (Chair, LUGPA Health Policy Committee); Mara R. Holton, MD (Vice-Chair, LUGPA Health Policy Committee); and Scott B. Sellinger, MD (LUGPA Secretary, Political Affairs Committee)

6:00pm

Adjourn

6:00pm–7:00pm

Educational Product Theater – Golden Cliff
Supported by Myovant Sciences

7:00pm–7:30pm

Welcome Cocktail Reception – Golden Cliff

Evening

Dinner on Own

Thursday, July 15, 2021

7:00am–10:30am

Registration Desk Opens

7:30am–11:30am

Exhibits Open

7:30am–8:15am

Educational Product Theater – Golden Cliff
Supported by AstraZeneca

8:15am–8:30am

Morning Break for Exhibits

8:30am–10:00am

SESSION 2: Biomarkers and Genetic Testing
Moderators: Alan H. Bryce, MD, and Leonard G. Gomella, MD, FACS

8:30am–8:40am

Prostate Cancer Early Detection 2021
Peter R. Carroll, MD, MPH

8:40am–8:50am

Active Surveillance Update 2021
Laurence Klotz, MD, FRCSC

8:50am–9:00am

Understanding and Hereditary Testing for the Urologist
Raoul S. Concepcion, MD, FACS

9:00am–9:15am

Panel Discussion
Moderator: Alan H. Bryce, MD

9:15am–9:25am

Germline Genetics in Prostate Cancer
Brian T. Helfand, MD, PhD

9:25am–9:35am

Risk Assessment (Early-in-Life PSA, PROMPT test)
Gerald L. Andriole, Jr., MD

9:35am–9:45am

Use of Polygenic Risk Scores for Prostate Cancer Screening
Peter R. Carroll, MD, MPH

9:45am–9:55am

Review of Sentinel Assay
Laurence Klotz, MD, FRCSC

9:55am–10:10am

Panel Discussion
Moderator: Leonard G. Gomella, MD, FACS

10:10am–10:20am

Morning Break for Exhibits

10:30am–12:00pm

SESSION 3: Practice Management 
Moderator: R. Jonathan Henderson, MD

10:30am–10:40am

Overview/Update of LUGPA
Jonathan Henderson, MD

10:40am–11:00am

Starting an Advanced Prostate Cancer Clinic  Moderator: Scott B. Sellinger, MD
Panelists: R. Jonathan Henderson, MD; Jason M. Hafron, MD; and Bryan A. Mehlhaff, MD

11:00am–11:10am

Negotiating Pay for Call Contracts with Hospitals
Evan R. Goldfischer, MD, MBA (LUGPA President-Elect)

11:10am–11:30am

Private Equity Panel Discussion
Moderator: Deepak A. Kapoor, MD, FACS
Panelists: Peter M. Knapp, MD, FACS; David M. Albala, MD; and Scott B. Sellinger, MD

11:30am–11:40am

How to Optimize a Telehealth Visit
Evan R. Goldfischer, MD, MBA

11:40am–12:00pm

Telemedicine and Post-COVID Treatment Panel Discussion – Moderator: Mara R. Holton, MD
Panelists: Bryan A. Mehlhaff, MD; Evan R. Goldfischer, MD, MBA; Jason M. Hafron, MD; and David M. Albala, MD

12:00pm

Adjourn

12:00pm–12:45pm

Educational Product Theater – Golden Cliff
Supported by Tolmar Pharmaceuticals

12:30pm–3:30pm

Open Advisory Board Slots

3:00pm–3:30pm

Afternoon Break for Exhibits

3:30pm–6:00pm

SESSION 4: Localized Prostate Cancer, Including ADT and Radiation Oncology
Moderators: Laurence Klotz, MD, FRCSC; James A. Eastham, MD, FACS; and Steven E. Finkelstein, MD, FACRO

3:30pm–3:40pm

Updates in ADT: What’s New
Laurence Klotz, MD, FRCSC

3:40pm–3:50pm

ADT Plus Radiation: A Radiation Oncologist’s Perspective
Steven E. Finkelstein, MD, FACRO

3:50pm–4:00pm

Agonists vs. Antagonists: An Ongoing Debate
Marc B. Garnick, MD

4:00pm–4:25pm

LUGPA ADT Panel Discussion
Moderator: Raoul S. Concepcion, MD, FACS
Panelists: Scott B. Sellinger, MD; R. Jonathan Henderson, MD; Peter M. Knapp, MD, FACS; and David M. Albala, MD

4:25pm–4:35pm

Active Surveillance in Favorable Intermediate-Risk Prostate Cancer
James A. Eastham, MD, FACS

4:35pm–4:45pm

Can We Trust the TRUS Biopsies? Case Presentations and Discussion
Francisco G. La Rosa, MD

4:45pm–5:10pm

Panel Discussion: Management of High-Risk, Non-Metastatic Prostate Cancer – The Case for Surgery
Moderator: James A. Eastham, MD, FACS
Panelists: Francisco G. La Rosa, MD; Steven E. Finkelstein, MD, FACRO; and Peter R. Carroll, MD, MPH

5:10pm–5:20pm

Management of Biochemical Recurrence After Surgery or Radiation
Peter R. Carroll, MD, MPH

5:20pm–5:30pm

Contemporary Brachytherapy: A View from the ABS
Brian J. Moran, MD

5:30pm–5:40pm

Updates in Radiation Oncology: A View from ACRO
Steven E. Finkelstein, MD, FACRO

5:40pm–6:00pm

Panel Discussion 
Moderator: Steven E. Finkelstein, MD, FACRO
Panelists: James A. Eastham, MD, FACS; Francisco G. La Rosa, MD; and Peter R. Carroll, MD, MPH

6:00pm

Adjourn

6:00pm–7:30pm

LUGPA Sponsored Cocktail Reception – Conference Center Terrace
Guest Speaker: Congressman Peter Murphy, MD

7:30pm–Evening

Dinner on Own

7:30pm–9:00pm

Faculty Dinner – Aerie Mountain Room

Friday, July 16, 2021

7:30am–10:30am

Registration Desk Opens

7:30am–11:30am

Exhibits Open

7:30am–8:15am

Educational Product Theater – Golden Cliff
Supported by Janssen Biotech

8:15am–8:30am

Morning Break for Exhibits

8:30am–12:00pm

SESSION 5: Next Generation Imaging: Focus on PSMA
Supported by AAA/Novartis, Lantheus, and Telix Pharma

8:30am–8:40am

Next Generation Imaging
Phillip J. Koo, MD

8:40am–9:35am

Part 1: Current Status of PSMA Diagnostics

8:40am–9:00am
Ga-PSMA-11
Jérémie Calais, MD, MSc

9:00am–9:20am
Pyl
Michael A. Gorin, MD 

9:20am–9:35am
Panel Discussion
Moderator: Phillip J. Koo, MD

 

9:35am–10:55am

Part 2: Patient Management at Initial Diagnosis and Biochemical Recurrence

9:35am–9:50am
Impact at Initial Diagnosis
Peter R. Carroll, MD, MPH 

9:50am–10:05am
Oligometastatic Disease
Robert E. Reiter, MD 

10:05am–10:20am
Radiation Oncology Perspective
Steven E. Finkelstein, MD, FACRO 

10:20am–10:55am
Panel Discussion with Cases
Moderator: Phillip J. Koo, MD

10:55am–11:10am

Break to Visit Exhibits

11:10am–12:10pm

Part 3: Current Trials with PSMA and Other Therapies
Moderator: Daniel P. Petrylak, MD

11:10am–11:20am
VISION Trial
Daniel J. George, MD, or Andrew J. Armstrong, MD, ScM, FACP 

11:20am–11:30am
Future Trials with Lutetium-177
Daniel P. Petrylak, MD 

11:30am–11:40am
Radium-223 Trial Updates
Daniel P. Petrylak, MD

11:40am–11:50am
Integrating Theranostics Into a Group Practice  
David M. Albala, MD

11:50am–12:10pm
Panel Discussion
Moderator: Phillip J. Koo, MD

12:10pm

Adjourn

12:15pm–1:00pm

Educational Product Theater – Golden Cliff
Supported by Bayer Oncology

3:00pm–3:30pm

Afternoon Break for Exhibits

3:30pm–5:00pm

SESSION 6: Advanced Imaging
Moderators: Gerald L. Andriole, Jr., MD, and Robert E. Reiter, MD

3:30pm–3:40pm

Current and Emerging Liquid Diagnostics
David Crawford, MD

3:40pm–3:50pm

Treatment for Prostate Cancer with MRI-Guided Transurethral Ultrasound
Laurence Klotz, MD, FRCSC

3:50pm–4:00pm

High-Resolution 29 MHZ Micro-Ultrasound in Diagnosis of Primary and Recurrent Prostate Cancer
Gerald L. Andriole, Jr., MD

4:00pm–4:15pm

Panel Discussion
Moderator: Gerald L. Andriole, Jr., MD

4:15pm–4:25pm

MRI: Can It Be Used to Plan Ablative Therapies?
Robert E. Reiter, MD

4:25pm–4:35pm

Next Generation Imaging for Localization of Recurrent Prostate Cancer
Brian T. Helfand, MD, PhD

4:35pm–4:45pm

Updates on Imaging Technology for Group Practice
Jitesh Patel, MD

4:45pm–5:00pm

Panel Discussion
Moderator: Robert E. Reiter, MD

5:00pm–6:00pm

Poster Session – Oral Presentations
Moderator: TBD
(Top 12 posters presented for 5 minutes each)

6:00pm

Adjourn

Evening

Dinner on Own

Saturday, July 17, 2021

7:30am–10:30am

Registration Desk Opens

7:30am–11:30am

Exhibits Open

7:30am–8:15am

Educational Product Theater – Golden Cliff
Supported by Astellas/Pfizer

8:15am–8:30am

Morning Break for Exhibits

8:30am–10:00am

SESSION 7: Advanced Prostate Cancer – Part 1
Moderator: Daniel P. Petrylak, MD

8:30am–8:45am

Efficacy of Enzalutamide Plus ADT in Men with De Novo (M1) mHSPC Versus Progression to mHSPC: Post Hoc Analysis of the Phase III ARCHES Trial
Daniel P. Petrylak, MD

8:45am–9:00am

Final Results from ACIS Trial of Apalutamide Plus Abiraterone/Prednisone in Patients (pts) with Chemo-Naïve Metastatic Castration-Resistant Prostate Cancer (mCRPC)
R. Jonathan Henderson, MD

9:00am–9:15am

Safety of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer From Extended Follow-Up in the Phase III ARAMIS Trial
Raoul S. Concepcion, MD, FACS

9:15am–9:30am

Role of PARP Inhibitors
Daniel P. Petrylak, MD

9:30am–10:15am

Breaking News and Panel Discussion
Moderator: Daniel P. Petrylak, MD

10:15am–10:30am

Morning Break for Exhibits

10:30am–11:45am

SESSION 8: Advanced Prostate Cancer – Part 2: Challenging Cases
Moderator: Raoul S. Concepcion, MD, FACS

11:45am

Adjourn

11:45am–12:30pm

Educational Product Theater – Golden Cliff
Supported by Exact Sciences

3:00pm–3:30pm

Afternoon Break for Exhibits

3:30pm–6:00pm

SESSION 9: Targeted Focal Therapy
Moderator: Thomas J. Polascik, MD, FACS

3:30pm–3:45pm

MRI-Guided Focal Therapy: Initial Quality-of-Life and Oncologic Outcomes
James A. Eastham, MD, FACS

3:45pm–4:00pm

MRI-Guided Transperineal Prostate Biopsy
Michael A. Gorin, MD

4:00pm–4:15pm

Freehand Transperineal Prostate Biopsy Under Local Anesthesia
Michael A. Gorin, MD

4:15pm–4:30pm

Panel Discussion
Moderator: Thomas J. Polascik, MD, FACS

4:30pm–4:45pm

Focal Brachytherapy
Steven E. Finkelstein, MD, FACRO

4:45pm–5:00pm

HIFU
E. David Crawford, MD

5:00pm–5:15pm

Cryotherapy
Thomas J. Polascik, MD, FACS

5:15pm–5:30pm

Surveillance After Image-Targeted Focal Therapy
Thomas J. Polascik, MD, FACS

5:30pm–6:00pm

Panel Discussion
Moderator: Thomas J. Polascik, MD, FACS
Panelists: E. David Crawford, MD; James A. Eastham, MD, FACS; Steven E. Finkelstein, MD, FACRO; and Michael A. Gorin, MD

6:00pm

Adjourn

6:00pm–7:00pm

IPCU Cocktail Reception and Awards

Evening

On Own

Sunday, July 18, 2021

Departures

Accommodations & Transportation

The Cliff Lodge at Snowbird
9320 Cliff Lodge Drive
Snowbird, UT 84092

The Cliff Lodge at Snowbird is one of North America’s most iconic ski lodges. However, there is an abundance of summer activities in the area to enjoy in July. See below for a list of recommended summer activities.

Lodging Health & Safety Measures from the Cliff Lodge

  • Masks are required in communal indoor spaces, as well as outdoors when within the Snowbird Village, on the Tram, or while engaging in organized summer activities. Masks are not required when eating, swimming, hiking, or inside your hotel room. Masks are available for guests upon request.
  • Enhanced hotel room cleaning with a focus on high-touch surfaces including door handles, kitchen areas, refrigerators, faucets, toilets, remote controls, directories, telephones, and alarm clocks.
  • Clean and disinfect high-touch surfaces frequently in common areas such as fitness centers, swimming pools, hot tubs, elevators, stairwells, restrooms, and escalators.
  • Sanitize payment systems, pens, and front desk area after every guest.
  • Remove non-essential items from hotel rooms including magazines, notepads, and pens.


For more information, see The Cliff Lodge page with this link: https://www.snowbird.com/health-safety/

ROOM RATES:
A single or double Standard Bedroom (QN/QN) is $179/night

RESORT FEE:
$10.00 per room per night will be added to the guest room charges and paid by the individuals as an incidental charge. Amenities currently include high-speed wireless internet in lodging rooms and most public space, free self parking at all lodges, fitness center use, in-room coffee at the Cliff Lodge and hot beverages in the Lodge at Snowbird lobby, USA Today, 800 number phone calls, faxing and first 15 minutes free computer use in business center. A portion of the Snowbird resort fee is matched by a congressional grant through the National Forest Foundation funding local organizations such as the Cottonwood Canyons Foundation.

ROOM TAXES:
All lodging rates and resort fees are exclusive of the Utah state sales tax (currently 12.32%). Tax rates and fees are subject to change and the current taxes and fees in effect at the time of your meeting will apply.

RESERVATION METHODS:
Individual Guests will make own lodging reservations directly with Snowbird’s Central Reservation Office by going to this link:

https://reservations.snowbird.com/default.aspx?p=&group=CJP721&arrival=07/14/2021&depart=07/18/2021&bookingstep=1

calling 1-800-453-3000 or by emailing lodging@snowbird.com. Individuals are encouraged to identify themselves as part of the group block (Carden Jennings Publishing/31st IPCU conference) to receive the discounted group rate.

ROOM CHARGES:
Individuals Pay All Charges: Individuals will be responsible for payment of their own lodging, taxes and fees, additional nights, and incidental charges at time of check-out. A credit card imprint will be taken at time of check-in.

LODGING DEPOSIT for Individuals:
A one-night deposit per room for room rate, tax and fees is required at the time the reservation is made. Final balance for the entire stay will be automatically charged to the credit card on file three (3) days prior to the arrival date.

LODGING CANCELLATIONS:
The individual reservation lodging deposit is fully refundable up to three (3) days prior to the arrival date. Reservations canceled within three (3) days prior to the arrival date will be charged one (1) night’s lodging, tax, and fees. After check-in, reservations are fully non-refundable. No-shows, delayed arrivals and early departures are considered cancellations.

CHECK IN/OUT:
Check-in time begins at 4:00 pm and is guaranteed by 6:00 pm. Check-out time is 11:00 am. Luggage storage is available through bell service for guests arriving prior to check-in time and for those involved in meetings or activities that extend past check-out time. Photo ID is required at check-in along with a credit card or cash deposit for incidental charges. Debit cards are not recommended.

DISCOUNTED CLIFF SPA ACCESS:
Access to the exclusive Cliff Spa will be discounted 50% for IPCU 31 attendees registered as overnight guests with our group block at the above rates. Guests must show their hotel registration card at the 9th-floor spa desk which identifies them with your group (minimum age 16). The Cliff Spa includes a relaxing solarium, full-service salon, eucalyptus steam room, dry sauna, yoga room, rooftop lap pool, large hot tub plus extensive cardiovascular and training equipment. Attendees may participate in yoga classes at no additional charge. Daily access fee is waived with the purchase of select treatments. The Cliff Spa will provide attendees with 20% off select spa treatments. Discount cannot be used in conjunction with any other discounts, promotions, or packages.

CONFERENCE ATTIRE:
Attire is business casual. Since meeting room temperatures and personal comfort levels vary, it is recommended that you bring a sweater or jacket to the educational activities.

PARKING:
Self-parking is complimentary for group attendees at all Snowbird lodges. Valet parking is available at the Cliff Lodge currently at $16.00, per day per car. Prices are subject to change.

AIRPORT TRANSPORTATION:
Airport shuttles may be arranged while booking lodging through Snowbird Central Reservations (800-453-3000) or up to 48 hours prior to arrival. Current group round-trip pre-paid price is $78.00 per person. Walk-ups are accepted at a higher rate on a space available basis at the Canyon Transportation desk located in the baggage claim area of the Salt Lake City International Airport. Cancellations received within 48 hours of arrival are non-refundable. Driver gratuity not included and prices are subject to change.

TRIP INSURANCE:
Snowbird offers trip insurance on an individual basis for cancellations or travel interruptions. The insurance may be purchased through Central Reservations. It pays for charges assessed due to unforeseen circumstances or death, injury, or illness to the guest, or traveling companion. Insurance must be purchased at time of booking room reservation.

RECOMMENDED SUMMER ACTIVITIES:

  • Alpine Slide – Race down 1,300 linear feet of twist and turns
  • Mountain CoasterFull of twists, turns and horizontal loops, with 3,120 linear feet of excitement
  • Aerial Tram RidesRide the Tram to the 11,000 foot summit of Hidden Peak
  • Mountain FlyerFly down the 1000 ft zip line suspended above Chickadee
  • Ropes Course
  • Vertical Drop
  • Bungy TrampolineBouncy fun in the sun
  • Climbing Wall4-Station and Cliff Lodge climbing walls
  • HikingHikes and walks for all ability levels. Guided hikes upon request.
  • Mountain Bikes & ScootersHit the trails on bikes or scooters
  • Kids Fishing PondHunt the big ones in the Snowbird fishing pond
  • Sports EquipmentBasketball, Volleyball, Badminton, Horseshoe rentals
  • Off-site adventuresArrangements for river rafting or guided fly fishing trips on Utah’s most beautiful rivers.
  • Pool & Hot TubsComplimentary outdoor pools and hot tubs are heated and open year-round.
  • Fitness RoomComplimentary fitness room available.
  • Cliff Game RoomHidden away on Level A is a spacious game room with billiard tables, air hockey and a wide variety of video games. Barrier-free Trail – Snowbird features a wheelchair accessible, barrier-free trail. This one-mile round-trip nature walk begins at the Snowbird Plaza and ends at a beautiful observation deck overlooking the Gad Valley. Adults and Children of all ages and abilities can enjoy this low impact hike.
  • Horseback RidingGuided horseback riding tours are available in the beautiful Mineral Basin
  • Tennis Court
To view more information about summer activities in Snowbird, see this page from The Cliff Lodge: https://www.snowbird.com/summer-activities/

Invited Faculty

E. David Crawford, MD

E. David Crawford, MD

University of California, San Diego
San Diego, California

Daniel P. Petrylak, MD

Daniel P. Petrylak, MD

Yale Cancer Center
New Haven, Connecticut

Phillip J. Koo, MD

Phillip J. Koo, MD

Banner MD Anderson Cancer Center
Phoenix, Arizona

Scott B. Sellinger, MD

Scott B. Sellinger, MD

Advanced Urology Institute
Tallahassee, Florida

David M. Albala, MD

David M. Albala, MD

Crouse Hospital
Syracuse, New York

Gerald L. Andriole, Jr., MD

Gerald L. Andriole, Jr., MD

Washington University School of Medicine
St. Louis, Missouri

Andrew J. Armstrong, MD, ScM, FACP

Andrew J. Armstrong, MD, ScM, FACP

Duke University
Durham, North Carolina

Alan H. Bryce, MD

Alan H. Bryce, MD

Mayo Clinic
Scottsdale, Arizona

Jérémie Calais, MD, MSc

Jérémie Calais, MD, MSc

University of California, Los Angeles
Los Angeles, California

Peter R. Carroll, MD, MPH

Peter R. Carroll, MD, MPH

University of California, San Francisco
San Francisco, California

Raoul S. Concepcion, MD

Raoul S. Concepcion, MD

Comprehensive Prostate Center
Nashville, Tennessee

James A. Eastham, MD, FACS

James A. Eastham, MD, FACS

Memorial Sloan-Kettering Cancer Center
New York, New York

Steven E. Finkelstein, MD, FACRO

Steven E. Finkelstein, MD, FACRO

Florida Cancer Affiliates/The US Oncology Network
Panama City, Florida

Marc B. Garnick, MD

Marc B. Garnick, MD

Harvard University
Boston, Massachusetts

Daniel J. George, MD

Daniel J. George, MD

Duke University School of Medicine
Durham, North Carolina

Evan R. Goldfischer, MD, MBA

Evan R. Goldfischer, MD, MBA

Premier Medical Group
Poughkeepsie, New York

Leonard G. Gomella, MD, FACS

Leonard G. Gomella, MD, FACS

(virtual)
Thomas Jefferson University
Philadelphia, Pennsylvania

Michael A. Gorin, MD

Michael A. Gorin, MD

Urology Associates
Cumberland, Maryland

Jason M. Hafron, MD

Jason M. Hafron, MD

Michigan Institute of Urology
Bloomfield, Michigan

Brian T. Helfand, MD, PhD

Brian T. Helfand, MD, PhD

NorthShore University Health System
Evanston, Illinois

R. Jonathan Henderson, MD

R. Jonathan Henderson, MD

Urology Partners LLC
Shreveport, Louisiana

Mara R. Holton, MD

Mara R. Holton, MD

Anne Arundel Medical Center
Annapolis, Maryland

Deepak A. Kapoor, MD, FACS

Deepak A. Kapoor, MD, FACS

Integrated Medical Professionals
Farmingdale, New York

Laurence Klotz, MD, FRCSC

Laurence Klotz, MD, FRCSC

University of Toronto
Toronto, Ontario, Canada

Peter M. Knapp, MD

Peter M. Knapp, MD

Urology of Indiana LLC
Indianapolis, Indiana

Francisco G. La Rosa, MD

Francisco G. La Rosa, MD

University of Colorado, Denver
Aurora, Colorado

Bryan A. Mehlhaff, MD

Bryan A. Mehlhaff, MD

Oregon Urology Institute
Springfield, Oregon

Brian J. Moran, MD

Brian J. Moran, MD

Chicago Prostate Center
Westmont, Illinois

Mark A. Moyad, MD, MPH

Mark A. Moyad, MD, MPH

University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan

Jitesh Patel, MD

Jitesh Patel, MD

Advanced Urology
Snellville, Georgia

Wendy L. Poage, MHA

Wendy L. Poage, MHA

Prostate Conditions Education Council
Centennial, Colorado

Thomas J. Polascik, MD, FACS

Thomas J. Polascik, MD, FACS

Duke University Medical Center
Durham, North Carolina

Robert E. Reiter, MD

Robert E. Reiter, MD

Geffen UCLA Medical Center
Los Angeles, California

Wesley Smith, PhD

Wesley Smith, PhD

University of Miami
Miami, Florida

CME Information

This conference will be accredited for AMA PRA Category 1 CreditsTM.

Registration

During these times, Grand Rounds in Urology and the International Prostate Cancer Update are committed to you and helping your practice run as best as it can.

By registering for this conference, you agree to our standard Conference Registration and Attendance Terms and Conditions agreement, which is available online at: Conference Registration and Attendance Terms and Conditions.

Health and Safety Precautions: The health and safety of IPCU attendees, faculty, sponsors, and staff are of the utmost importance to us. We are actively working with the host hotel to ensure proper safety and sanitary conditions. To that end, the following safety precautions will be in place:

  • All participants will be asked to wear a mask when not eating or drinking.
  • The general session room will be arranged to maintain social distancing.
  • The general session room will be sanitized at the conclusion of the day and attendees will be asked to sit in their same seats from the day before.
  • All food will be plated; there will be no buffet food service.
  • Hotel staff will be wearing masks, as well as gloves when serving food.
  • All meals and ancillary events outside of the general session will maintain social distancing.
  • Sleeping rooms will be fully cleaned and sanitized between guests. Housekeeping will not enter your room during your stay. Guests will be able to obtain additional towels or other items upon request only.

We are monitoring all local and CDC guidelines and will make adjustments to these policies as necessary. For more information on Snowbird’s Commitment to Clean, please feel free to visit their cleanliness site: https://www.snowbird.com/health-safety/

If you have any questions, please contact Amy Collier at acollier@cjp.com

COVID-19 DISCLAIMER: An inherent risk of exposure to COVID-19 and other more common contagions exists in any public place where people are present. COVID-19 is an extremely contagious disease that can lead to severe illness and even death in a small percentage of the population, especially those with weakened immune systems. For your safety and convenience, we are endeavoring to take appropriate precautions, as detailed above. Even with our best efforts, however, there is no guarantee that you can avoid exposure to COVID-19 or other common pathogens, whether at our conference or elsewhere. Please note that, as further detailed in our Conference Registration and Attendance Terms and Conditions Agreement (the “Registration Agreement”), which must be reviewed and agreed to during the registration process, all conference attendees voluntarily assume ALL RISKS related to any possible exposure to COVID-19. We encourage you to read the Registration Agreement carefully, as it contains other important terms, including other disclaimers and limitations on liability.

Support Opportunities

To inquire about support opportunities, please contact:

Marc Weathersby, Chief Marketing Officer
Tel:434-817-2000, x193    Cell: 434-989-5508
Fax 434-817-2020    mweathersby@cjp.com

Exhibit and Sponsor Prospectus

Poster Submission

1. When is the abstract submission deadline?
June 1, 2021

2. What are the submission guidelines?
When submitting your abstract, please follow these formatting guidelines:

  1. Include a title
  2. Maximum of 500 words
  3. Single-spaced
  4. 10 point font
  5. Times New Roman
  6. Author names must be spelled out
  7. List the institution, city, state, country, and e-mail address of the presenting author
  8. To submit your abstract, e-mail your document to David Utz at dutz@cjp.com  and Amy Collier at acollier@cjp.com.

3. How will the posters be displayed?
The posters are displayed electronically as a PowerPoint slide. They will be projected on the main screen at the conference so everyone can see them. Here is an example:

Presenters are also allowed two slides for the 2-minute presentation. Slides must be formatted to have a 16×9 aspect ratio. Here is an example from last year:

4. Who can give the oral poster presentation?
Anyone involved with the poster; it does not need to be a lead investigator or healthcare provider. However, please provide the name of the presenter to us in advance, by December 30, if possible.

5. Are the poster sessions CME accredited?
No

6. Are encore posters allowed?
Yes

7. I have other questions, who can I contact?
Amy at acollier@cjp.com or 703-944-2828.

NOTE: The posters will also be printed in an abstract book. Along with the abstract slide image itself, text similar to the following will be printed in the abstract book:

Meeting organized by Grand Rounds in Urology, a division of Carden Jennings Publishing, Co., Ltd.

View content from previous International Prostate Cancer Update Meetings

=

Have Questions? Contact Us.